Definitive Contract 36C25220C0031
Award Date
10/1/19
Potential Completion Date
3/31/22
Potential Value
$3.8M
Federal Agency
Veterans Integrated Service Network 12
Awardee
Cepheid
Ultimate Awardee
Not listed
NAICS Category
325413 - In-Vitro Diagnostic Substance Manufacturing
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Sunnyvale, CA 94089, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Veterans Affairs (VA) Veterans Health Administration awarded a purchase order to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, to provide MRSA reagents. The firm-fixed-price contract, valued at $139,486.20, was awarded on October 1, 2019 and has a completion date of September 30, 2020. This contract supports the VA's clinical diagnostic programs and does not have a set-aside designation. Cepheid, a subsidiary of Danaher Corporation, is a major supplier...
The Department of Veterans Affairs (VA) awarded a $70,467.00 firm-fixed-price delivery order contract to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, including tests for infectious diseases and genetic conditions. The contract is for MRSA CPRR testing and services, with a performance period through September 30, 2024. Cepheid is the prime contractor and original equipment manufacturer, providing diagnostic testing equipment, reagents, consumables, and associated...
This contract was awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, including tests for infectious diseases. The contract, valued at $2,779,571.60, is for the delivery of MRSA test reagents to VA facilities in VISN 12 (Veterans Integrated Service Network 12). The contract is a Delivery Order placed under Cepheid's existing GSA Federal Supply Schedule (FSS) contract for In-Vitro Diagnostics,...
This is a firm fixed price contract awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, to provide MRSA reagents. The contract is a Blanket Purchase Agreement (BPA) call under the VA's Federal Supply Schedule (FSS) contract for In Vitro Diagnostics, Reagents, and Test Kits. The potential value of the award is $1,542,736.82, with a completion date of September 30, 2020. As the original equipment...
This is a federal contract award to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, including tests for infectious diseases and genetic conditions. The contract, with a ceiling value of $197,472.00, was awarded by the Veterans Integrated Service Network 12 (VISN 12), which is part of the U.S. Department of Veterans Affairs (VA). The contract is for the procurement of MRSA (Methicillin-resistant Staphylococcus aureus) test reagents and is not designated as a set-aside....
This is a delivery order contract awarded by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 10 to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, including tests for infectious diseases and genetic conditions. The contract, which has a ceiling value of $188,294.40, is for the provision of MRSA reagents under the VA's FSS-65-VII Indefinite Delivery Contract for In-vitro Diagnostics, Reagents, and Tests. The contract is a firm fixed-price...
This is a firm fixed price contract awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, including tests for infectious diseases and genetic conditions. The contract is for the provision of MRSA reagents under a Blanket Purchase Agreement (BPA) call, with a potential value of $13,255,076.99 and a completion date of September 30, 2021. The contract was awarded on October 1, 2018 and falls under...
This is a firm fixed-price delivery order awarded to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, by the Department of Veterans Affairs (VA) Veterans Health Administration. The contract is for the provision of MRSA (methicillin-resistant Staphylococcus aureus) testing products and services, including reagents, test kits, instruments, and testing platforms. The contract does not have a set-aside designation. The potential value of the award is $262,241.93, with a...
This is a firm-fixed price delivery order contract awarded by the Department of Veterans Affairs (VA) to Cepheid, a for-profit manufacturer of molecular diagnostic solutions. The contract, valued at $64,119.80, is for MRSA CPRR (Methicillin-resistant Staphylococcus aureus Colonization Prevalence and Risk Factors) testing and related services. The contract has an ultimate completion date of September 30, 2025. Cepheid is an experienced federal contractor, holding multiple indefinite delivery...
This is a firm fixed-price delivery order awarded by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 16 to Cepheid, a for-profit manufacturer of molecular diagnostic solutions. The $75,515.28 contract is for the provision of MRSA (methicillin-resistant Staphylococcus aureus) test kits under the VA's Federal Supply Schedule contract for In-Vitro Diagnostics, Reagents, and Test Kits. The contract has an ultimate completion date of September 30, 2017 and does not have...